ProfileGDS4814 / ILMN_1743103
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 92% 92% 92% 92% 92% 92% 92% 93% 95% 92% 93% 96% 93% 93% 94% 94% 91% 93% 93% 91% 90% 93% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)540.79892
GSM780708Untreated after 4 days (C2_1)502.42492
GSM780709Untreated after 4 days (C3_1)497.69192
GSM780719Untreated after 4 days (C1_2)523.83792
GSM780720Untreated after 4 days (C2_2)506.36792
GSM780721Untreated after 4 days (C3_2)537.95292
GSM780710Trastuzumab treated after 4 days (T1_1)563.99492
GSM780711Trastuzumab treated after 4 days (T2_1)587.70693
GSM780712Trastuzumab treated after 4 days (T3_1)936.93195
GSM780722Trastuzumab treated after 4 days (T1_2)568.80192
GSM780723Trastuzumab treated after 4 days (T2_2)618.2393
GSM780724Trastuzumab treated after 4 days (T3_2)1129.1296
GSM780713Pertuzumab treated after 4 days (P1_1)660.23993
GSM780714Pertuzumab treated after 4 days (P2_1)580.72893
GSM780715Pertuzumab treated after 4 days (P3_1)729.0294
GSM780725Pertuzumab treated after 4 days (P1_2)715.10894
GSM780726Pertuzumab treated after 4 days (P2_2)486.11191
GSM780727Pertuzumab treated after 4 days (P3_2)668.18493
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)579.14993
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)439.16591
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)404.25290
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)604.53593
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)461.45491